Skip to main content

Outsourcing in Clinical Trials DACH 2018 at Switzerland

 

Clinical courses

The global OCT series extends to Switzerland in 2018 to bring innovative and solutions-focused content to the DACH biopharmaceutical market.  Spinning off from the flagship OCT Europe event, this intimate audience of local players allows for focused, lucrative learning and networking on site. 

Through in depth research conducted with local biopharma companies, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology based themes within the clinical trial space locally.

DACH

Who should attend OCT DACH?
The OCT series provides an opportunity for all clinical trial Sponsors to extend their network both with industry colleagues and providers of services and solutions which enhance the output of clinical trials.

OCT Global Series
The objective of the OCT series is to deliver relevant content and networking to localised biopharma and device markets across the world. The events take place in biopharma clusters to support the local biopharma community in their clinical trial delivery.

EVENT OUTLOOK
1. Technology,  Innovation and Digital Focus
2. Collaborative relationships and effective selection of solution providers
3. Strategic oversight and monitoring

FIND MORE INFO>>

FIND MORE CONFERENCES AT PHARMATUTOR

Subscribe to Pharmatutor Job Alerts by Email